Breaking News

Sterling Pharma to Expand API Mfg. Capacity in Dudley, UK

To build and commission new process development labs and install additional commercial-scale manufacturing equipment for small molecule API manufacturing.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sterling Pharma Solutions, a global CDMO, entered the next phase of a multi-year investment strategy at its site in Dudley, UK. The company is investing £10 million to build and commission new process development laboratories and install additional commercial-scale manufacturing equipment to meet the continued growth in demand for small molecule API manufacturing.   The project, scheduled to be completed mid-2022, includes the installation of a 4.5 cubic meter hydrogenator, capable of pressure...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters